The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of enfortumab vedotin (EV) therapy in relation to prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial cancer (aUC).
 
Evangelia Vlachou
No Relationships to Disclose
 
Roy Elias
No Relationships to Disclose
 
Noah M. Hahn
Honoraria - MedScape
Consulting or Advisory Role - AstraZeneca; ImmunityBio; Incyte; Janssen; Merck; Mirati Therapeutics; Natera; Pfizer; Pfizer/EMD Serono; Protara Therapeutics; Seattle Genetics/Astellas; Verity Pharmaceuticals
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); EMD Serono/Merck (Inst); Genentech/Roche (Inst); HTG Molecular Diagnostics (Inst); Ikena Oncology (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pieris Pharmaceuticals (Inst); Seattle Genetics/Astellas (Inst)
 
David James McConkey
Honoraria - H3 Biomedicine; Janssen Oncology
 
Burles Avner Johnson
Patents, Royalties, Other Intellectual Property - Patent pending (owned by JHU, not affiliated with another company)
 
Jean H. Hoffman-Censits
Honoraria - Clovis Oncology; Gilead Sciences; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Foundation medicine; Gilead Sciences; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); EMD Serono (Inst); Foundation Medicine; Genentech; Genentech; Sanofi
Travel, Accommodations, Expenses - Roche/Genentech